UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000054154
Receipt number R000061674
Scientific Title The change characteristics of the High Frequency Variability Index (HFVI) during ultrasound-guided peripheral nerve block in lower limb surgery
Date of disclosure of the study information 2024/04/16
Last modified on 2024/04/15 12:57:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The change characteristics of the High Frequency Variability Index (HFVI) during ultrasound-guided peripheral nerve block in lower limb surgery

Acronym

The change characteristics of the High Frequency Variability Index (HFVI) during ultrasound-guided peripheral nerve block in lower limb surgery

Scientific Title

The change characteristics of the High Frequency Variability Index (HFVI) during ultrasound-guided peripheral nerve block in lower limb surgery

Scientific Title:Acronym

The change characteristics of the High Frequency Variability Index (HFVI) during ultrasound-guided peripheral nerve block in lower limb surgery

Region

Japan


Condition

Condition

patients recieving the lower limb surgery

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

to evaluate whether the High Frequency Variability Index(HFVI) can be used as an indicator of efficacy of the peripheral nerve block (PNB) by revealing the effect of effective PNB on HFVI

To investigate whether opioids can be administered based on the change characteristics of HFVI after nerve blocks, taking into account the impact of pain that cannot be treated with PNB such as Tourniquet Pain, and to verify if it can serve as an indicator for adequate opioid administration.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

the changes of HFVI after PNB

Key secondary outcomes


Comparison of opioid administration between the group where opioid administration was guided by HFVI values and the group where opioids were administered conventionally


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

patients undergoing the orthopaedic lower limb surgery

Key exclusion criteria

the patients with serious cardiovascular dosease, who are American Society of Anestheologists physical status class 3 or more, who are administered an anticholinergic agent,with arrhythmia or implanted pacemaker and inappropriate recordind of HFVI.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Motoi
Middle name
Last name Kumagai

Organization

Iwate medical universty hospital

Division name

Department of Anesthesiology

Zip code

020

Address

2-1-1, Idaidori, Yahaba-cho, Shiwa-gun, Iwate, Japan

TEL

0196137111

Email

motoij@iwate-med.ac.jp


Public contact

Name of contact person

1st name Motoi
Middle name
Last name Kumagai

Organization

Iwate medical university hospital

Division name

Department of Anesthesiology

Zip code

028-3695

Address

2-1-1, Idaidori, Yahaba-cho, Shiwa-gun, Iwate, Japan

TEL

0196137111

Homepage URL


Email

motoij@iwate-med.ac.jp


Sponsor or person

Institute

Iwate medical university hospital

Institute

Department

Personal name



Funding Source

Organization

Iwate medical university hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Iwate medical university hospital

Address

2-1-1, Idaidori, Yahaba-cho, Shiwa-gun, Iwate, Japan

Tel

0196137111

Email

motoij@iwate-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 04 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 07 Month 01 Day

Date of IRB

2023 Year 10 Month 26 Day

Anticipated trial start date

2023 Year 12 Month 19 Day

Last follow-up date

2024 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Nothing in particular


Management information

Registered date

2024 Year 04 Month 15 Day

Last modified on

2024 Year 04 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061674


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name